Sort
30,917 grants matching “tumor microenvironment”
Targeting GARP-TGFbeta for Immunotherapy of Non-Small Cell Lung Cancer
$641,336Zihai Li · Ohio State University · R01 · FY2024 · CA
Targeting Aldehyde Dehydrogenase for Cancer Prevention
$641,281Gavin P. Robertson · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2020 · CA
Novel dietary interventions for reducing obesity-associated breast cancer
$641,100Paul S Maclean · University Of Colorado Denver · R01 · FY2025 · CA
Stress, the Immune System and Basal Cell Carcinoma
$641,044Ohio State University · R01 · FY2005 · CA
Mechanisms of myeloid cell driven pancreatic plasticity and carcinogenesis
$640,945Marina Pasca Di Magliano · University Of Michigan At Ann Arbor · R01 · FY2025 · CA
Biomarkers of Vision Loss in Children with Optic Pathway Gliomas
$640,762Robert Andrew Avery · Children'S Hosp Of Philadelphia · R01 · FY2021 · EY
Overcoming Hypoxic Resistance in Non-Small Cell Lung Cancer By Targeting Mitochondrial Metabolism
$640,703Nicholas C Denko · Ohio State University · R01 · FY2025 · CA
Protein kinase C and lung carcinogenesis
$640,695Marcelo Gabriel Kazanietz · University Of Miami School Of Medicine · R01 · FY2024 · CA
Project-1: Defining the mechanisms by which neurons promote breast cancer metastasis
$640,681Sohail F. Tavazoie · Rockefeller University · U54 · FY2023 · CA
Metabolic reprogramming to boost the fitness of anti-tumor immunity against metastatic colon cancer
$640,583Semir Beyaz · Cold Spring Harbor Laboratory · R37 · FY2025 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$640,569William Brian Reeves · University Of Texas Hlth Science Center · R01 · FY2021 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$640,551Rebecca L Aft · Washington University · R01 · FY2022 · CA
Synergized Immune and Tumor Cell Bone Marrow Biomarkers to Predict Recurrence in Triple Negative Breast Cancer
$640,551Rebecca L Aft · Washington University · R01 · FY2023 · CA
(PQ#3) Novel tumor intrinsic PD-L1 signals direct tumor immune cell infiltration
$640,547Tyler J. Curiel · University Of Texas Hlth Science Center · R01 · FY2020 · CA
Molecular Determinants and Therapeutic Consequences of Immune Heterogeneity in Cancer
$640,513Robert H Vonderheide · University Of Pennsylvania · R01 · FY2019 · CA
The adaptor protein Crk in immune responses
$640,503Dongfang Liu · Rutgers Biomedical And Health Sciences · R01 · FY2025 · AI
Chemoimmunoprevention of EGFR-Driven Non-Small Cell Lung Cancer
$640,450Ming You · Medical College Of Wisconsin · R01 · FY2020 · CA
ER stress and UPR in non-alcoholic steatohepatitis and hepatocellular carcinoma
$640,385Randal J. Kaufman · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2019 · CA
Planning and Evaluation Core
$640,316Jason A Wilder · Northern Arizona University · U54 · FY2022 · CA
Surrogate biomarkers for assessing changes in pancreatic cancer tumor microenvironment
$640,316Marvin M Doyley · University Of Rochester · R01 · FY2021 · EB
CANCAN - COLDSPRING
$640,225Tobias Janowitz · Cold Spring Harbor Laboratory · OT2 · FY2024 · CA
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$640,182Harry H Yoon · Mayo Clinic Rochester · R01 · FY2021 · CA
Molecular Imaging Guidance for Potentiating Chemoimmunotherapy in Pancreatic Cancer using Photodynamic Priming
$640,089Girgis Obaid · University Of Texas Dallas · R01 · FY2024 · EB
Establishing a mechanistic basis for enhanced tumorigenesis under chronic circadian disruption
$640,055Katja A Lamia · Scripps Research Institute, The · R01 · FY2023 · CA
Eco-evolutionary drivers of clonal dynamics during UV-induced skin carcinogenesis (PQ3)
$640,021Kenneth Y Tsai · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2021 · CA